Shanrong Biotechnology (SRBT, $0.2) was a top loser over the last three months, falling -4 to $0.2 per share. A.I.dvisor analyzed 369 stocks in the Financial Conglomerates Industry for the 3-month period ending August 16, 2024, and found that of them (7) exhibited an Uptrend while of them (2) demonstrated a Downtrend.